Analysis of hematopoietic lineage plasticity by using inducible transcription factors

利用诱导转录因子分析造血谱系可塑性

• 批准号: 14370298
• 负责人: NAKAJIMA Hideaki
• 金额: $ 8.9万
• 依托单位: The University of Tokyo
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (B)
• 财政年份: 2002
• 资助国家: 日本
• 起止时间: 2002 至 2003
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-14370298/
• 关键词: differentiation; transcription factor; C; EBPα; PU.1; transigenic mouse; hematopoiesis; EBPε

In order to investigate the molecular mechanism of differentiation and possible lineage switch or trans-differentiation in various hematopoietic lineages, we generated inducible form of myeloid transcription factors C/EBP α and PU.1 and examined their effect in vitro or in vivo. Full length C/EBP a and PU.1 were fused in frame with ligand binding domain of estrogen receptor (C/EBP α -ER and PU.1-ER) so that they can be activated by 4-hydroxy tamoxifen (4-HT). We subcloned. C/EBP α -ER and PU.1-ER into retrovirus vector, pMX-IRES-GFP and infected virus to BaF3 cells. Interestingly, 4-HT treatment of BaF3/CEBP α -ER, BaF3/PU.1l-ER cells induced growth arrest and apoptosis, indicating that C/EBP α -ER and PU.1-ER are working properly. Next we subcloned Cl EBP α -ER and PU.1-ER in H-2K promoter vector made transgenic mice. We obtained transgene integration in 8 lines for C/ EBP a -ER and 5 lines for PU.1-ER. RT-PCR analysis showed that mRNA is expressed in 5 out of 8 C/EBP α -ER transgenics and only one line expressed C/EBP α -ER protein by western blot. C/EBP α -ER was expressed highly in thymus and spleen, moderately in bone marrow and peripheral blood. Gel-shift assay showed that C/ EBP α -ER protein bound to conserved C/EBP binding sequence in response to 4-HT. With these mice in our hand, we are now planning to investigate how ectopically induced C/ EBP α activity affects differentiation of hematopoietic cells at various developmental stages.

为了研究不同造血系分化的分子机制和可能的谱系转换或跨分化，我们构建了髓系转录因子C/EBPα和PU.1的诱导形式，并检测了它们在体外和体内的作用。将全长C/EBPa和PU1与雌激素受体的配体结合区(C/EBPα-ER和PU.1-ER)融合在一起，使其能被4-羟基三苯氧胺(4-HT)激活。我们进行了亚克隆。C/eBPα-ER和PU1-ER分别构建成逆转录病毒载体pMX-IRES-GFP和感染病毒。有趣的是，4-羟色胺处理BaF_3/CEBPα-ER，BaF_3/PU_3/PU_1-ER细胞发生生长停滞和细胞凋亡，表明C/E_BPα-ER和PU_1-ER正常工作。接下来，我们将C1EBP、α-ER和PU1-ER亚克隆到H-2K启动子载体中，制成转基因小鼠。获得了8株C/EBPa-ER和5株PU.1-ER的转基因整合。RT-PCR分析表明，在8株C/EBpα-ER转基因株中，有5株表达α-ER蛋白，Western印迹显示只有1株表达C/EBPDNA-ER蛋白。C/EBP型α-ER在胸腺和脾中高表达，在骨髓和外周血中中等表达。凝胶漂移分析表明，4-羟色胺处理后，C/eBPα-ER蛋白与保守的C/eBP结合序列结合。有了这些小鼠，我们现在计划研究异位诱导的C/EBPα活性如何影响不同发育阶段的造血细胞的分化。

项目成果

Carpino N.: "Identification, cDNA cloning, and targeted deletion of p70, a novel, ubiquitously expressed SH3 domain-containing protein."Mol.Cell.Biol.. 22. 7491-7500 (2002)

Carpino N.：“p70 的鉴定、cDNA 克隆和靶向删除，p70 是一种新型、普遍表达的含有 SH3 结构域的蛋白质。”Mol.Cell.Biol.. 22. 7491-7500 (2002)

Kumagai H.: "Identification and characterization of a new pair of immunoglobulin-like receptors LMIR1 and 2 derived from murine bone marrow-derived mast cells."Biochem.Biophys.Res.Commun.. 307. 719-729 (2003)

Kumagai H.：“来自鼠骨髓源性肥大细胞的一对新的免疫球蛋白样受体 LMIR1 和 2 的鉴定和表征。”Biochem.Biophys.Res.Commun.. 307. 719-729 (2003)

Truong BT.: "CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia."Blood. 101. 1141-1148 (2003)

Truong BT.：“CCAAT/增强子结合蛋白抑制急性髓性白血病的白血病表型。”血液。

Watanabe N., Nakajima H., Suzuki H., Oda A., Matsubara Y., Moroi M., Terauchi Y., Kadowaki T., Suzuki H., Koyasu S., Ikeda Y., Hanada M.: "Functional phenotype of phosphoinositide 3-kinase p85alpha-null platelets characterized by an impaired response to G

渡边 N.、中岛 H.、铃木 H.、小田 A.、松原 Y.、森井 M.、寺内 Y.、门胁 T.、铃木 H.、小安 S.、池田 Y.、花田 M.：“功能性

Kitamura T., Koshino Y., Shibata F., Oki T., Nakaiima H., Nosaka T., Kumagai H.: "Retrovirus-mediated gene transfer and expression cloning : powerful tools in functional genomics."Exp.Hematol.. 31. 1007-1014 (2003)

Kitamura T.、Koshino Y.、Shibata F.、Oki T.、Nakaiima H.、Nosaka T.、Kumagai H.：“逆转录病毒介导的基因转移和表达克隆：功能基因组学的强大工具。”Exp.Hematol..